Molecular cancer diagnostics in your laboratory


NEOonsite is a streamlined technology platform that allows you to perform all molecular genetic tests offered by NEO New Oncology in your own lab. NEOonsite is available as a CE-marked product for molecular cancer diagnostics as well as an RUO product for clinical research laboratories. NEOonsite combines reagents for sample analysis with a comprehensive bioinformatic data analysis and a user-friendly software for data interpretation.


NEOonsite offers:

  • Comprehensive support in establishing the NEOonsite workflow for hybrid capture-based next generation sequencing tumor analysis in your laboratory
  • Parallel, sensitive analysis of relevant gene alterations (point mutations, small insertions and deletions, copy number alterations, gene fusions, microsatellite instability* (MSI), tumor mutational burden* (TMB) in clinical routine and research settings
  • High quality bioinformatic data analysis by NEO New Oncology
  • Your full data control on all raw and analysis files
  • User-friendly data evaluation including an interface to a visualization software, for your data interpretation using NEOdiagnosis software

For molecular genetic analyses, hybrid capture reagents  are available for various questions in routine diagnostics or clinical research. Learn more.


NEOonsite – the workflow



We would be pleased to provide detailed information on the possibility of establishing NEO New Oncology's hybrid capture NGS-based molecular tumor analysis in your lab.

Please contact us for further information at

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact NEO New Oncology GmbH for further details.